Treatment Of Myasthenia Gravis Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
IMVT | D | Immunovant, Inc. | -0.65 | |
GTBP | F | GT Biopharma, Inc. | 1.37 |
Related Industries: Biotechnology
Related ETFs - A few ETFs which own one or more of the above listed Treatment Of Myasthenia Gravis stocks.
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
BTEC | D | Principal Healthcare Innovators Index ETF | 1.15 | |
XBI | C | SPDR S&P Biotech ETF | 1.06 | |
LABU | D | Direxion Daily S&P Biotech Bull 3X Shares | 0.68 | |
NSCS | A | Nuveen Small Cap Select ETF | 0.61 | |
BBC | C | Virtus LifeSci Biotech Clinical Trials ETF | 0.57 |
Compare ETFs
Related Industries:
Biotechnology
- Treatment Of Myasthenia Gravis
Treatment of myasthenia gravis typically involves medications, such as cholinesterase inhibitors, immunosuppressants, and corticosteroids, as well as other therapies, such as plasmapheresis and thymectomy. The goal of treatment is to reduce the severity of symptoms and improve the patient's quality of life.
Recent Comments
- TraderMike on Market Recap for Friday, March 8, 2024
- Don_Marat on Market Recap for Friday, March 8, 2024
- TraderMike on Trades of the Week: Feb 12 - Feb 16, 2024
- Cos3 on Trades of the Week: Feb 12 - Feb 16, 2024
- SwingTradeBot on Market Recap for Tuesday, February 27, 2024
From the Blog
Featured Articles